Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|April 5, 2017
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II TrialTheo Ruers, Frits Van Coevorden, Cornelis J A Punt, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2019
Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Jean Marc Phelip, David Tougeron, David Léonard, et al.
Cancer Research|April 19, 2006
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancerAstrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, et al.
BMC Cancer|April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocksHeiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancerGraeme J Poston, René Adam, Steven Alberts, et al.
The Lancet. Oncology|October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialBernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Annals of Surgery|February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
The Lancet. Oncology|July 5, 2005
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trialBernard Nordlinger, Philippe Rougier, Jean-Pierre Arnaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2020
Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCDHans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, et al.
Pageof 10